Too often, people promote remedies for irritable bowel syndrome that have little to no scientific backing.

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...

New research examines the long-term use of medication for irritable bowel syndrome and points to potential risks associated ...

A massive long-term study tracking more than 650,000 Americans with irritable bowel syndrome is raising new concerns about the safety of some commonly used treatments.

Commonly used medications for irritable bowel syndrome (IBS), like antidepressants, are linked to a modest absolute increase in mortality risk. | Drug Discovery And Development ...

Dietary treatment is more effective than medications in irritable bowel syndrome (IBS). These are the findings of a study conducted at the University of Gothenburg. With dietary adjustments, more than ...

Some Irritable bowel syndrome (IBS) medications show an association with increased long-term risk The overall risk for individual patients remains small, but it is important to consider Personalized ...

The European Medicines Agency (EMA) wants better medicinal products to treat irritable bowel syndrome. The disorder, which affects an estimated 20% of the population of western countries by the agency ...

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2-5, 2026, in Chicago ...

NEW IBS research highlights persistent pain treatment gaps and points to peripheral nerve targets for future, safer therapies ...

A large new study links common IBS drugs like loperamide and diphenoxylate to a higher risk of death. Experts say the risk is ...

Irritable bowel syndrome (IBS) causes chronic gut discomfort; it's characterized by abdominal pain, bloating, gas, distension, and bowel problems like diarrhea and constipation. It's estimated that as ...